Paperpal Prime Logo

Expert Opinion on Drug Metabolism and Toxicology : Impact Factor & More

eISSN: 1744-7607pISSN: 1742-5255

Aims and Scope of Expert Opinion on Drug Metabolism and Toxicology

Expert Opinion on Drug Metabolism & Toxicology is a monthly peer-reviewed medical journal publishing review articles on ADME-Tox. It was established in 2005 and is published by Taylor and Francis. The editor-in-chief is Luis Valerio (Food and Drug Administration). Less

Key Metrics

CiteScore
7.2
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q1Toxicology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Opinion on Drug Metabolism and Toxicology

Expert Opinion on Drug Metabolism and Toxicology Journal Specifications

Overview
Publisher TAYLOR & FRANCIS LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2005
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Opinion on Drug Metabolism and Toxicology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Opinion on Drug Metabolism and Toxicology

The use of natural language processing in predictive toxicology
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant gram-negative pathogens
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach
  • 25 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Optimizing tamoxifen therapy in breast cancer: a narrative review of dose escalation in patients with CYP2D6 polymorphisms
  • 24 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Transplacental pharmacokinetics and developmental toxicity of chemotherapeutic agents: a comparative analysis of fetal and pediatric exposure profiles
  • 3 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Complex in vitro model developers’ perspective on advanced hepatic in vitro culture methods for predictive drug safety
  • 3 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
The use of natural language processing in predictive toxicology
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
An update on beta-lactam-beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant gram-negative pathogens
  • 3 Jul 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach
  • 25 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Optimizing tamoxifen therapy in breast cancer: a narrative review of dose escalation in patients with CYP2D6 polymorphisms
  • 24 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Transplacental pharmacokinetics and developmental toxicity of chemotherapeutic agents: a comparative analysis of fetal and pediatric exposure profiles
  • 3 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology
Complex in vitro model developers’ perspective on advanced hepatic in vitro culture methods for predictive drug safety
  • 3 Jun 2026
  • Expert Opinion on Drug Metabolism & Toxicology

FAQs on Expert Opinion on Drug Metabolism and Toxicology